Literature DB >> 29730251

Effects of prefrontal theta-burst stimulation on brain function in treatment-resistant depression: A randomized sham-controlled neuroimaging study.

Cheng-Ta Li1, Mu-Hong Chen2, Chi-Hung Juan3, Ren-Shyan Liu4, Wei-Chen Lin2, Ya-Mei Bai2, Tung-Ping Su5.   

Abstract

BACKGROUND: Theta-burst transcranial magnetic stimulation (TBS) can quickly modulate brain activity and can be used to treat treatment-resistant depression (TRD). Whole-brain analytical research has revealed that left high-frequency PFC rTMS modulates brain activity in anterior cingulate cortex (ACC) and the fronto-cingulo-temporal circuit. We aimed to investigate whether the prefrontal TBS's antidepressant mechanisms involve these regions.
METHODS: We designed a randomized, double-blind, sham-controlled neuroimaging study to investigate different mechanisms of TBS [i.e., continuous TBS (cTBS) and intermittent TBS (iTBS)]. This study included 56 TRD patients [67.8%: women; mean age (SD): 45.5 (10.6) years], who were randomly assigned to one of four groups [A: right prefrontal cTBS; B: left prefrontal iTBS; C: combined right prefrontal cTBS and left prefrontal iTBS; and D: sham-TBS]. We measured standard uptake values (SUV) of cerebral glucose metabolism, at rest, both before and after ten daily treatment sessions.
RESULTS: Group B and Group C had more responders than Group A and Group D (χ2 = 9.161, p = 0.027). In Group A, the SUV was significantly increased in the ACC and medial PFC (mPFC) after treatment, while the SUV was decreased in the right temporal cortex (p < 0.05, FWE-corrected for multiple comparisons). In contrast, in Group B, SUV was decreased in the ACC and mPFC and increased in the bilateral temporal cortex. Group C also had increased SUV in the bilateral temporal cortices.
CONCLUSION: Instead of observing inhibitory or facilitatory effects on the targeted prefrontal cortex, we found that the two-week prefrontal TBS protocols primarily modulated the fronto-cingulo-temporal circuit.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anterior cingulate cortex; Glucose metabolism; Major depression; Prefrontal cortex; Theta oscillation; Theta-burst stimulation

Mesh:

Year:  2018        PMID: 29730251     DOI: 10.1016/j.brs.2018.04.014

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  16 in total

Review 1.  Critical role of glutamatergic and GABAergic neurotransmission in the central mechanisms of theta-burst stimulation.

Authors:  Cheng-Ta Li; Ying-Zu Huang; Ya-Mei Bai; Shih-Jen Tsai; Tung-Ping Su; Chih-Ming Cheng
Journal:  Hum Brain Mapp       Date:  2019-01-01       Impact factor: 5.038

2.  Brain network effects by continuous theta burst stimulation in mal de débarquement syndrome: simultaneous EEG and fMRI study.

Authors:  Yafen Chen; Yoon-Hee Cha; Diamond Gleghorn; Benjamin C Doudican; Guofa Shou; Lei Ding; Han Yuan
Journal:  J Neural Eng       Date:  2021-11-30       Impact factor: 5.379

3.  Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial.

Authors:  Daniel M Blumberger; Benoit H Mulsant; Kevin E Thorpe; Shawn M McClintock; Gerasimos N Konstantinou; Hyewon H Lee; Sean M Nestor; Yoshihiro Noda; Tarek K Rajji; Alisson P Trevizol; Fidel Vila-Rodriguez; Zafiris J Daskalakis; Jonathan Downar
Journal:  JAMA Psychiatry       Date:  2022-09-21       Impact factor: 25.911

4.  Efficacy and brain mechanism of transcutaneous auricular vagus nerve stimulation for adolescents with mild to moderate depression: Study protocol for a randomized controlled trial.

Authors:  Xue Xiao; Xiaobing Hou; Zhangjing Zhang; Ying Li; Xue Yu; Yanhui Wang; Jing Tian; Ke Xu
Journal:  Pediatr Investig       Date:  2020-06-24

5.  High-frequency versus theta burst transcranial magnetic stimulation for the treatment of poststroke cognitive impairment in humans

Authors:  Po-Yi Tsai; Wang-Sheng Lin; Kun-Ting Tsai; Chia-Yu Kuo; Pei-Hsin Lin
Journal:  J Psychiatry Neurosci       Date:  2020-07-01       Impact factor: 6.186

6.  Treatment of mixed depression with theta-burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial.

Authors:  Diego Freitas Tavares; Paulo Suen; Carla Garcia Rodrigues Dos Santos; Doris Hupfeld Moreno; Leandro Da Costa Lane Valiengo; Izio Klein; Lucas Borrione; Pamela Marques Forte; André R Brunoni; Ricardo Alberto Moreno
Journal:  Neuropsychopharmacology       Date:  2021-06-30       Impact factor: 7.853

7.  The effects of individualised intermittent theta burst stimulation in the prefrontal cortex: A TMS-EEG study.

Authors:  Sung Wook Chung; Caley M Sullivan; Nigel C Rogasch; Kate E Hoy; Neil W Bailey; Robin F H Cash; Paul B Fitzgerald
Journal:  Hum Brain Mapp       Date:  2018-09-25       Impact factor: 5.038

8.  Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial.

Authors:  Diego Freitas Tavares; Carla Garcia Rodrigues Dos Santos; Leandro Da Costa Lane Valiengo; Izio Klein; Lucas Borrione; Pamela Marques Forte; Andre R Brunoni; Ricardo Alberto Moreno
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

9.  Commentary: Effectiveness of theta burst vs. high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomized non-inferiority trial.

Authors:  Cuilan Han; Zhongming Chen; Lin Liu
Journal:  Front Hum Neurosci       Date:  2018-06-25       Impact factor: 3.169

10.  Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity.

Authors:  Po-Han Chou; Yen-Feng Lin; Ming-Kuei Lu; Hsin-An Chang; Che-Sheng Chu; Wei Hung Chang; Taishiro Kishimoto; Alexander T Sack; Kuan-Pin Su
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.